A Study to Compare the Efficacy and Safety of Ifosfamide and Etoposide With or Without Lenvatinib in Children, Adolescents and Young Adults With Relapsed and Refractory Osteosarcoma
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Merck Sharp & Dohme LLC
Related studies linked through entity extraction aliases.
Pembrolizumab + Platinum Doublets Without Radiation for Programmed Death-ligand 1 (PD-L1) ≥50% Locally Advanced NSCLC
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
A Study of Pembrolizumab in Combination With Cisplatin and Pemetrexed in Advanced Malignant Pleural Mesothelioma (MPM) (MK-3475-A17)
- Status
- COMPLETED
- Phase
- PHASE1
Efficacy, Safety, and Tolerability of Gebasaxturev (V937) Administered Intravenously or Intratumorally With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone in Participants With Advanced/Metastatic Melanoma (V937-011)
- Status
- TERMINATED
- Phase
- PHASE2
A Study of the CD73 Inhibitor LY3475070 Alone or in Combination With Pembrolizumab in Participants With Advanced Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Imipenem-Relebactam Pharmacokinetics in Augmented Renal Clearance
- Status
- COMPLETED
- Phase
- PHASE1
Study of Ifinatamab Deruxtecan (DS-7300a, I-DXd) in Participants With Advanced Solid Malignant Tumors
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
The Importance of Muscle Function in Patients With Disseminated Bladder Cancer
- Status
- UNKNOWN
- Phase
- N/A
Corifollitropin Alfa and Embryo Morphokinetics
- Status
- COMPLETED
- Phase
- N/A
A Study of Intratumoral/Intralesional Administration of V938 in Combination With Pembrolizumab (MK-3475) in Participants With Advanced/Metastatic or Recurrent Malignancies (V938-001)
- Status
- TERMINATED
- Phase
- PHASE1
Phase 1 Trial of LVGN6051 as Single Agent and in Combination With Keytruda (Pembrolizumab) in Advanced or Metastatic Malignancy
- Status
- COMPLETED
- Phase
- PHASE1
Study Assessing MTD, Safety, Tolerability, PK and Anti-tumor Effects of LNS8801alone and With Pembrolizumab
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
MK-8228 (Letermovir) in the Prevention of Human Cytomegalovirus (CMV) Infection and Disease in Adult Japanese Kidney Transplant Recipients (MK-8228-042)
- Status
- COMPLETED
- Phase
- PHASE3
Study of GSK3359609 and Pembrolizumab in Programmed Death Receptor 1-ligand 1 (PD-L1) Positive Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
- Status
- TERMINATED
- Phase
- PHASE3
Impact of Deep Versus Standard Muscle Relaxation on Intra-operative Safety
- Status
- COMPLETED
- Phase
- NA
Study of Olaparib (MK-7339) in Combination With Pembrolizumab (MK-3475) in the Treatment of Homologous Recombination Repair Mutation (HRRm) and/or Homologous Recombination Deficiency (HRD)-Positive Advanced Cancer (MK-7339-007/KEYLYNK-007)
- Status
- COMPLETED
- Phase
- PHASE2
Rintatolimod and Pembrolizumab for the Treatment of Refractory Metastatic or Unresectable Colorectal Cancer
- Status
- WITHDRAWN
- Phase
- PHASE2
Fecal Microbiota Transplant and Pembrolizumab for Men With Metastatic Castration Resistant Prostate Cancer.
- Status
- UNKNOWN
- Phase
- PHASE2
A Study of CHeckpoint Inhibitors in Men With prOgressive Metastatic Castrate Resistant Prostate Cancer Characterized by a Mismatch Repair Deficiency or Biallelic CDK12 Inactivation
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
An Open Label Study of Bavituximab and Pembrolizumab in Advanced Gastric and GEJ Cancer Patients
- Status
- COMPLETED
- Phase
- PHASE2